Intelligence Platform

Patents

Browse 200 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8337848

Monoclonal antibody for APP

University College Cardiff Consultants Limited · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337853

Monoclonal antibodies that bind or neutralize dengue virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337854

Monoclonal antibodies against dengue and other viruses with deletion in Fc region

granted patent

US 8313746

Human monoclonal antibodies against hendra and nipah viruses

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8299218

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263747

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8105598

Human monoclonal antibodies that specifically bind IGF-II

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8092796

Monoclonal antibodies against ANGPTL4

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088908

Humanized anti-prostate stem cell antigen monoclonal antibody

The Regents of the University of California · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071323

Human monoclonal antibodies that bind human insulin like growth factors and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022175

Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999079

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7988971

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7959923

Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

The Regents of the University of California · Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7935796

Monoclonal antibodies against ANGPTL3

LEXICON PHARMACEUTICALS, INC. · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919095

Anti-IL-6 monoclonal antibodies

VACCINEX, INC. · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7914788

Monoclonal antibodies against orthopoxviruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7872110

Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV

United Biomedical, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7824681

Human monoclonal antibodies that specifically bind IGF-II

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803913

Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies us

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7794714

Newcastle disease virus monoclonal antibodies

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718779

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700738

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7658923

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted